1
|
Madhvani RV, Angelini M, Xie Y, Pantazis A, Suriany S, Borgstrom NP, Garfinkel A, Qu Z, Weiss JN, Olcese R. Targeting the late component of the cardiac L-type Ca2+ current to suppress early afterdepolarizations. ACTA ACUST UNITED AC 2016; 145:395-404. [PMID: 25918358 PMCID: PMC4411259 DOI: 10.1085/jgp.201411288] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Early afterdepolarizations (EADs) associated with prolongation of the cardiac action potential (AP) can create heterogeneity of repolarization and premature extrasystoles, triggering focal and reentrant arrhythmias. Because the L-type Ca(2+) current (ICa,L) plays a key role in both AP prolongation and EAD formation, L-type Ca(2+) channels (LTCCs) represent a promising therapeutic target to normalize AP duration (APD) and suppress EADs and their arrhythmogenic consequences. We used the dynamic-clamp technique to systematically explore how the biophysical properties of LTCCs could be modified to normalize APD and suppress EADs without impairing excitation-contraction coupling. Isolated rabbit ventricular myocytes were first exposed to H2O2 or moderate hypokalemia to induce EADs, after which their endogenous ICa,L was replaced by a virtual ICa,L with tunable parameters, in dynamic-clamp mode. We probed the sensitivity of EADs to changes in the (a) amplitude of the noninactivating pedestal current; (b) slope of voltage-dependent activation; (c) slope of voltage-dependent inactivation; (d) time constant of voltage-dependent activation; and (e) time constant of voltage-dependent inactivation. We found that reducing the amplitude of the noninactivating pedestal component of ICa,L effectively suppressed both H2O2- and hypokalemia-induced EADs and restored APD. These results, together with our previous work, demonstrate the potential of this hybrid experimental-computational approach to guide drug discovery or gene therapy strategies by identifying and targeting selective properties of LTCC.
Collapse
Affiliation(s)
- Roshni V Madhvani
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - Marina Angelini
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - Yuanfang Xie
- Department of Pharmacology, University of California, Davis, Davis, CA 95616
| | - Antonios Pantazis
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - Silvie Suriany
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - Nils P Borgstrom
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - Alan Garfinkel
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - Zhilin Qu
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - James N Weiss
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| | - Riccardo Olcese
- Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 Division of Molecular Medicine, Department of Anesthesiology, Department of Medicine (Cardiology), Department of Physiology, Department of Integrative Biology and Physiology, Cardiovascular Research Laboratory, and Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095
| |
Collapse
|
2
|
Krishnamoorthi S, Perotti LE, Borgstrom NP, Ajijola OA, Frid A, Ponnaluri AV, Weiss JN, Qu Z, Klug WS, Ennis DB, Garfinkel A. Simulation Methods and Validation Criteria for Modeling Cardiac Ventricular Electrophysiology. PLoS One 2014; 9:e114494. [PMID: 25493967 PMCID: PMC4262432 DOI: 10.1371/journal.pone.0114494] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2014] [Accepted: 11/07/2014] [Indexed: 01/24/2023] Open
Abstract
We describe a sequence of methods to produce a partial differential equation model of the electrical activation of the ventricles. In our framework, we incorporate the anatomy and cardiac microstructure obtained from magnetic resonance imaging and diffusion tensor imaging of a New Zealand White rabbit, the Purkinje structure and the Purkinje-muscle junctions, and an electrophysiologically accurate model of the ventricular myocytes and tissue, which includes transmural and apex-to-base gradients of action potential characteristics. We solve the electrophysiology governing equations using the finite element method and compute both a 6-lead precordial electrocardiogram (ECG) and the activation wavefronts over time. We are particularly concerned with the validation of the various methods used in our model and, in this regard, propose a series of validation criteria that we consider essential. These include producing a physiologically accurate ECG, a correct ventricular activation sequence, and the inducibility of ventricular fibrillation. Among other components, we conclude that a Purkinje geometry with a high density of Purkinje muscle junctions covering the right and left ventricular endocardial surfaces as well as transmural and apex-to-base gradients in action potential characteristics are necessary to produce ECGs and time activation plots that agree with physiological observations.
Collapse
Affiliation(s)
- Shankarjee Krishnamoorthi
- Department of Mechanical and Aerospace Engineering, University of California Los Angeles, Los Angeles, California, United States of America
| | - Luigi E. Perotti
- Department of Mechanical and Aerospace Engineering, University of California Los Angeles, Los Angeles, California, United States of America
| | - Nils P. Borgstrom
- Department of Bioengineering, University of California Los Angeles, Los Angeles, California, United States of America
| | - Olujimi A. Ajijola
- Department of Medicine (Cardiology), University of California Los Angeles, Los Angeles, California, United States of America
| | - Anna Frid
- Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, California, United States of America
| | - Aditya V. Ponnaluri
- Department of Mechanical and Aerospace Engineering, University of California Los Angeles, Los Angeles, California, United States of America
| | - James N. Weiss
- Department of Medicine (Cardiology), University of California Los Angeles, Los Angeles, California, United States of America
| | - Zhilin Qu
- Department of Medicine (Cardiology), University of California Los Angeles, Los Angeles, California, United States of America
| | - William S. Klug
- Department of Mechanical and Aerospace Engineering, University of California Los Angeles, Los Angeles, California, United States of America
| | - Daniel B. Ennis
- Department of Bioengineering, University of California Los Angeles, Los Angeles, California, United States of America
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, United States of America
| | - Alan Garfinkel
- Department of Medicine (Cardiology), University of California Los Angeles, Los Angeles, California, United States of America
- Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, California, United States of America
- * E-mail:
| |
Collapse
|